Similar articles for PMID: 30275217

Year	Number of Results
2012	1
2014	3
2015	13
2016	33
2017	35
2018	32
2019	28
2020	25
2021	14
2022	6
2023	4
2024	0

1

Prognostic Impact of PD-L2 Expression and Association with PD-L1 in Patients with Small-cell Lung Cancer.

Takamori S, Takada K, Azuma K, Jogo Y, Kinoshita F, Kozuma Y, Matsubara T, Haratake N, Akamine T, Toyokawa G, Hirai F, Tagawa T, Okamoto I, Nakanishi Y, Kawahara A, Akiba J, Oda Y, Maehara Y. Takamori S, et al. Anticancer Res. 2018 Oct;38(10):5903-5907. doi: 10.21873/anticanres.12934. Anticancer Res. 2018. PMID: 30275217

2

PD-L2 Expression as a Potential Predictive Biomarker for the Response to Anti-PD-1 Drugs in Patients with Non-small Cell Lung Cancer.

Takamori S, Takada K, Toyokawa G, Azuma K, Shimokawa M, Jogo T, Yamada Y, Hirai F, Tagawa T, Kawahara A, Akiba J, Okamoto I, Nakanishi Y, Oda Y, Hoshino T, Maehara Y. Takamori S, et al. Anticancer Res. 2018 Oct;38(10):5897-5901. doi: 10.21873/anticanres.12933. Anticancer Res. 2018. PMID: 30275216

3

A Clinicopathological and Prognostic Analysis of PD-L2 Expression in Surgically Resected Primary Lung Squamous Cell Carcinoma.

Matsubara T, Takada K, Azuma K, Takamori S, Toyokawa G, Haro A, Osoegawa A, Tagawa T, Kawahara A, Akiba J, Okamoto I, Nakanishi Y, Oda Y, Hoshino T, Maehara Y. Matsubara T, et al. Ann Surg Oncol. 2019 Jun;26(6):1925-1933. doi: 10.1245/s10434-019-07257-3. Epub 2019 Feb 27. Ann Surg Oncol. 2019. PMID: 30815803

4

The expression of PD-L1 protein as a prognostic factor in lung squamous cell carcinoma.

Takada K, Okamoto T, Toyokawa G, Kozuma Y, Matsubara T, Haratake N, Akamine T, Takamori S, Katsura M, Shoji F, Oda Y, Maehara Y. Takada K, et al. Lung Cancer. 2017 Feb;104:7-15. doi: 10.1016/j.lungcan.2016.12.006. Epub 2016 Dec 12. Lung Cancer. 2017. PMID: 28213003

5

Prognostic Impact of Programmed Death-Ligand 2 Expression in Primary Lung Adenocarcinoma Patients.

Takamori S, Takada K, Azuma K, Jogo T, Shimokawa M, Toyokawa G, Hirai F, Tagawa T, Kawahara A, Akiba J, Okamoto I, Nakanishi Y, Oda Y, Hoshino T, Maehara Y. Takamori S, et al. Ann Surg Oncol. 2019 Jun;26(6):1916-1924. doi: 10.1245/s10434-019-07231-z. Epub 2019 Feb 27. Ann Surg Oncol. 2019. PMID: 30815801

6

A Comprehensive Analysis of Programmed Cell Death Ligand-1 Expression With the Clone SP142 Antibody in Non-Small-Cell Lung Cancer Patients.

Takada K, Toyokawa G, Okamoto T, Shimokawa M, Kozuma Y, Matsubara T, Haratake N, Akamine T, Takamori S, Katsura M, Shoji F, Oda Y, Maehara Y. Takada K, et al. Clin Lung Cancer. 2017 Sep;18(5):572-582.e1. doi: 10.1016/j.cllc.2017.02.004. Epub 2017 Mar 2. Clin Lung Cancer. 2017. PMID: 28318951

7

Accurate expression of PD-L1/L2 in lung adenocarcinoma cells: A retrospective study by double immunohistochemistry.

Shinchi Y, Komohara Y, Yonemitsu K, Sato K, Ohnishi K, Saito Y, Fujiwara Y, Mori T, Shiraishi K, Ikeda K, Suzuki M. Shinchi Y, et al. Cancer Sci. 2019 Sep;110(9):2711-2721. doi: 10.1111/cas.14128. Epub 2019 Jul 31. Cancer Sci. 2019. PMID: 31294893 Free PMC article.

8

Expression of PD-1 and Its Ligands, PD-L1 and PD-L2, in Smokers and Never Smokers with KRAS-Mutant Lung Cancer.

Calles A, Liao X, Sholl LM, Rodig SJ, Freeman GJ, Butaney M, Lydon C, Dahlberg SE, Hodi FS, Oxnard GR, Jackman DM, Jänne PA. Calles A, et al. J Thorac Oncol. 2015 Dec;10(12):1726-35. doi: 10.1097/JTO.0000000000000687. J Thorac Oncol. 2015. PMID: 26473645 Free article.

9

Programmed death-1 ligand 1 and 2 are highly expressed in pleomorphic carcinomas of the lung: Comparison of sarcomatous and carcinomatous areas.

Kim S, Kim MY, Koh J, Go H, Lee DS, Jeon YK, Chung DH. Kim S, et al. Eur J Cancer. 2015 Nov;51(17):2698-707. doi: 10.1016/j.ejca.2015.08.013. Epub 2015 Aug 29. Eur J Cancer. 2015. PMID: 26329973

10

Prognostic value of programmed death-1, programmed death-ligand 1, programmed death-ligand 2 expression, and CD8(+) T cell density in primary tumors and metastatic lymph nodes from patients with stage T1-4N+M0 gastric adenocarcinoma.

Gao Y, Li S, Xu D, Chen S, Cai Y, Jiang W, Zhang X, Sun J, Wang K, Chang B, Wang F, Hong M. Gao Y, et al. Chin J Cancer. 2017 Jul 29;36(1):61. doi: 10.1186/s40880-017-0226-3. Chin J Cancer. 2017. PMID: 28754154 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

170 results

Results by year